Seeing Is Believing
Currently out of the existing stock ratings of Tao Levy, 35 are a BUY (79.55%), 9 are a HOLD (20.45%).
Analyst Tao Levy, currently employed carries an average stock price target met ratio of 88.89% that have a potential upside of 20.58% achieved within 159 days. Previously, Tao Levy worked at WEDBUSH.
Tao Levy’s has documented 83 price targets and ratings displayed on 9 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on MASI, Masimo at 13-Dec-2017.
Analyst best performing recommendations are on NVCR (NOVOCURE LTD).
The best stock recommendation documented was for ISRG (INTUITIVE SURGICAL) at 3/26/2014. The price target of $57.11 was fulfilled within 7 days with a profit of $9.93 (21.05%) receiving and performance score of 30.07.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$20
$6.64 (49.70%)
$20
3 months 15 days ago
(09-Aug-2024)
2/9 (22.22%)
$8.98 (81.49%)
154
Buy
$12
$-1.36 (-10.18%)
$16
10 months 5 days ago
(19-Jan-2024)
1/3 (33.33%)
$3.22 (36.67%)
213
Buy
$15
$1.64 (12.28%)
$11
11 months 3 days ago
(21-Dec-2023)
9/13 (69.23%)
$7.85 (109.79%)
272
Buy
$16
$2.64 (19.76%)
$18
1 years 3 months 2 days ago
(22-Aug-2023)
1/2 (50%)
$9.61 (150.39%)
70
Buy
$25
2 years 8 months 13 days ago
(11-Mar-2022)
2/3 (66.67%)
$3.6 (16.82%)
144
What Year was the first public recommendation made by Tao Levy?